Plalab Placenta R-20
FDA Label NDC 70326-103

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Renocell Co., Ltd for the product Plalab Placenta R-20 (NDC 70326-103). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding plalab placenta cream r-20, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Plalab Placenta Cream R-20

Cream (Cream)

Cream (Cream)

* Please review the disclaimer below.